Apotex Amitriptyline

Apotex Amitriptyline Class Action Canada

Rice Harbut Elliott LLP is investigating a possible class action lawsuit, representing Canadians who were prescribed APO-Amitriptyline containing a nitrosamine impurity called N-nitrosodimethylamine (NDMA) above the acceptable limit. Drugs containing amitriptyline are used to treat patients with depression and chronic pain. At present, the recall involves the following products, although other lots may be affected:

Current Status
Overview

Current Status

The Amitriptyline Class Action is in the process of being dismissed as a result of the ruling in Palmer v. Teva Canada Limited, 2024 ONCA 220 (CanLII), https://canlii.ca/t/k3q9w. RHE will update this website to indicate the date on which the case is formally dismissed.

As of this date, class members need to take their own steps if they wish to advance their claims for Amitriptyline related damages. Class members should be aware that limitation periods may commence running pursuant to s. 39 of the Class Proceedings Act. Class members should consider immediately seeking legal advice and assistance on:

1. Commencing their own claims in the Provincial Superior Court where they reside;

2. Contacting counsel to assist them with such claims.

As our case will be dismissed, RHE cannot provide further assistance to Amitriptyline claimants. We encourage you to take the steps above if you believe you have an injury caused by these Defendants.

Overview

Our firm is seeking compensation for persons who received the above-listed drugs or other drugs from the same manufacturer that were contaminated with NDMA. Damages will be sought for individuals who were diagnosed with cancer and other individuals who received the drugs that were recalled and/or defective. The latter group may be entitled to compensation pursuant to consumer protection legislation in British Columbia and other Provinces and Territories.

If you received any of the below-listed drugs, you may be affected by this class action lawsuit.

If you have any recalled APO-Amitriptyline please preserve it as we may wish to arrange testing to determine the levels of toxins in the medication.

Apo-Amitriptyline
DIN, NPN, DIN-HIM – DIN 02403137
Dosage form – tablet
Strength – AMITRIPTYLINE HYDROCHLORIDE 10mg
Lot or serial number – RF0410

Companies:
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario

Marketing Authorization Holder:
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario

The full details of the Health Canada recall can be found here.

APOTEX AMITRIPTYLINE FORM

Note: You are not obliged to fill in this form to participate in this class action. If you choose to do so, you are not retaining RHE LLP to act on your behalf. Providing the information requested does not make you a client of RHE LLP. All information submitted will be treated as confidential and will only be released as required by law or as you may consent.

I provide my consent and agree herein to receive communications from RHE LLP, which may include announcements regarding class actions, practice updates, newsletters, publications, event invitations or other information that may be of interest. I understand that consent to receive these electronic communications may be withdrawn at any time by emailing reception@rhelaw.com.

Class Action Form

Contact Information

Name *

First

Last

Email *

Phone

FAX

Address (unit no., building/house number, street name)

City/ Town

Province

Postal Code

Date of Birth *

Personal Health Number *

Date of Prescription *

Date that you sought medical treatment for your symptoms

Are you aware of the Canadian APO-Amitriptyline recall? *

When did you become aware of the recall? *

Were you taking the drugs prior to the Health Canada public advisory on April 13, 2021? *

Have you been diagnosed with cancer? *

Please list all symptoms you experienced

Other comments

Consent *

I provide my consent and agree herein to receive communications from RHE LLP, which may include announcements regarding class actions, practice updates, newsletters, publications, event invitations or other information that may be of interest. I understand that I can unsubscribe to these emails at any time. I understand that some of the personal information that I provide may be stored or processed outside of British Columbia and/or Canada, on a US server, and will be kept confidential, subject to the potential that a foreign state may seek to access the data for “lawful access” purposes. If you have any questions about RHE’s policies and practices regarding service providers outside Canada, or about the collection, use, disclosure or storage of personal information by the service providers outside Canada, please contact reception@rhelaw.com.

Custom Captcha *